Four Years, Five Stages: the FDA’s Final Rule on LDTs
Read more
Blog
On May 14, 2024 | By The Velsera Clinical and Compliance Team
News
On April 4, 2024 | By The Velsera Clinical and Compliance Team
Velsera and Flywheel Team up to Support Multimodal Imaging Genomics Research
Read more
Video
On April 3, 2024 | By The Velsera Clinical and Compliance Team
Accelerating Drug Discovery: How GRAF Pangenomes Enable Enhanced Insights From Sequencing Data
Read more
News
On March 5, 2024 | By The Velsera Clinical and Compliance Team
Velsera Announces Appointment of Jamie Littlejohns as New Chief Executive Officer
Read more
Video
On February 29, 2024 | By The Velsera Clinical and Compliance Team
State of the Union: NGS Reimbursement
Read more
News
On November 15, 2023 | By The Velsera Clinical and Compliance Team
Faster, smarter clinical interpretation workflows unveiled on CGW platform
Read more
News
On November 3, 2023 | By The Velsera Clinical and Compliance Team
Velsera & Solaris Health expand access to genetic testing for urology patients
Read more
News
On November 2, 2023 | By The Velsera Clinical and Compliance Team
Velsera & NVIDIA make Parabricks available on Seven Bridges platform
Read more
Video
On October 13, 2023 | By The Velsera Clinical and Compliance Team
Unleashing the Power of Neoantigens
Read more
News
On October 4, 2023 | By The Velsera Clinical and Compliance Team
2023 BioTechX Europe
Read more
Video
On October 3, 2023 | By The Velsera Clinical and Compliance Team
MolDX at a Glance for NGS
Read more
Video
On September 21, 2023 | By The Velsera Clinical and Compliance Team
Comprehensive Clinical Molecular Results Reporting
Read more